| Literature DB >> 31132458 |
Donald M Lamkin1, Shreyesi Srivastava2, Karen P Bradshaw2, Jenna E Betz2, Kevin B Muy2, Anna M Wiese2, Shelby K Yee2, Rebecca M Waggoner2, Jesusa M G Arevalo3, Alexander J Yoon4, Kym F Faull5, Erica K Sloan6, Steve W Cole7.
Abstract
At the M2 terminal of the macrophage activation spectrum, expression of genes is regulated by transcription factors that include STAT6, CREB, and C/EBPβ. Signaling through β-adrenergic receptors drives M2 activation of macrophages, but little is known about the transcription factors involved. In the present study, we found that C/EBPβ regulates the signaling pathway between β-adrenergic stimulation and expression of Arg1 and several other specific genes in the greater M2 transcriptome. β-adrenergic signaling induced Cebpb gene expression relatively early with a peak at 1 h post-stimulation, followed by peak Arg1 gene expression at 8 h. C/EBPβ transcription factor activity was elevated at the enhancer region for Arg 1 at both 4 and 8 h after stimulation but not near the more proximal promoter region. Knockdown of Cebpb suppressed the β-adrenergic-induced peak in Cebpb gene expression as well as subsequent accumulation of C/EBPβ protein in the nucleus, which resulted in suppression of β-adrenergic-induced Arg1 gene expression. Analysis of genome-wide transcriptional profiles identified 20 additional M2 genes that followed the same pattern of regulation by β-adrenergic- and C/EBPβ-signaling. Promoter-based bioinformatic analysis confirmed enrichment of binding motifs for C/EBPβ transcription factor across these M2 genes. These findings pinpoint a mechanism that may be targeted to redirect the deleterious influence of β-adrenergic signaling on macrophage involvement in M2-related diseases such as cancer.Entities:
Keywords: Adrenergic receptor; Bioinformatics; Functional genomics; Macrophage; Transcription factor; Tumor immunology
Mesh:
Substances:
Year: 2019 PMID: 31132458 PMCID: PMC6660400 DOI: 10.1016/j.bbi.2019.05.034
Source DB: PubMed Journal: Brain Behav Immun ISSN: 0889-1591 Impact factor: 7.217